Comparison of Two Assays for Measuring Alpha-Fetoprotein in Amniotic Fluid
Author Information
Author(s): Edward J. Coombes, Brian J. Moody, Howard James, Ciaron Kelly
Primary Institution: Department of Chemical Pathology, Salisbury General Infirmary
Hypothesis
The study aims to evaluate the performance of a new DELFIA assay against the traditional IRMA assay for measuring alpha-fetoprotein in amniotic fluid.
Conclusion
The DELFIA assay proved to be a sensitive and convenient alternative to the IRMA assay for measuring alpha-fetoprotein in amniotic fluid.
Supporting Evidence
- The DELFIA assay showed an excellent correlation coefficient of 0.997 with the IRMA assay.
- In 53 of the 55 cases of open spina bifida and anencephaly, the DELFIA results were above the normal cut-off limits.
- The DELFIA assay allows for same-day results due to its shorter incubation time compared to the IRMA.
Takeaway
This study compared two tests to measure a substance in amniotic fluid that can indicate fetal health, finding that the new test works just as well as the old one but is faster and easier to use.
Methodology
The study used two techniques, DELFIA and IRMA, to measure alpha-fetoprotein levels in amniotic fluid samples collected from pregnancies.
Limitations
The study may have limitations related to the sample size and the specific clinical conditions of the pregnancies analyzed.
Participant Demographics
The study included 174 amniotic fluid samples collected from pregnancies, with 115 from normal pregnancies and 55 from abnormal pregnancies.
Want to read the original?
Access the complete publication on the publisher's website